BONFANTI, PAOLO

BONFANTI, PAOLO  

DIPARTIMENTO DI MEDICINA E CHIRURGIA (SCHOOL OF MEDICINE AND SURGERY)  

Mostra records
Risultati 1 - 20 di 371 (tempo di esecuzione: 0.029 secondi).
Titolo Tipologia Data di pubblicazione Autori File
Bimonthly Administered Long-Acting Cabotegravir and Rilpivirine Are Highly Effective and Well-Tolerated in People With Human Immunodeficiency Virus Above 65 Years 01 - Articolo su rivista 2026 Bonfanti Paolo +
Clinical characteristics and treatment patterns of carbapenem-resistant bloodstream infections in a multi-centre Italian cohort. 02 - Intervento a convegno 2026 Mezzadri LucaArtelli FioreBonfanti Paolo +
Cognitive and fine motor performance in people above 65 years of age with and without HIV 01 - Articolo su rivista 2026 Bonfanti Paolo +
Cognitive impairment in long-COVID: frequency, trajectories and risk factors in a cohort study from Italy 01 - Articolo su rivista 2026 Bonfanti P. +
Did the COVID-19 pandemic shift the landscape of late HIV diagnosis? 01 - Articolo su rivista 2026 Lapadula G.Puoti M.Russo D.Bonfanti P. +
Dyspnea and fatigue in Long-COVID: definition of risk factors and of DLCO-based phenotypes in a multicenter study of 765 patients from Italy 01 - Articolo su rivista 2026 Bonfanti Paolo +
Elizabethkingia anophelis: The First Italian Report of Neonatal Meningitis and Sepsis Associated With Breast-Pump–Expressed Milk 01 - Articolo su rivista 2026 Ventura M. L.Bonfanti P. +
HBV status modulates transaminase decrease after switching from tenofovir disoproxil fumarate to tenofovir alafenamide in people with HIV 01 - Articolo su rivista 2026 Lapadula G.Antolini L.Mezzadri L.Bonfanti P. +
HIV infection among adolescents and young adults in Italy: Epidemiology, viro-immunological and treatment outcomes 01 - Articolo su rivista 2026 Bonfanti Paolo +
Implementing the National Vaccination Plan in people with HIV in Italy: A survey among ICONA centres 01 - Articolo su rivista 2026 Puoti M.Lapadula G.Bonfanti P. +
Imported case of avian influenza A(H9N2) virus infection in a patient with miliary tuberculosis, Italy, March 2026 01 - Articolo su rivista 2026 Mezzadri, LucaBonfanti, Paolo +
Persisting or recurrent dermatological manifestations in Long-COVID: Data from a national cohort of 1741 patients from Italy 01 - Articolo su rivista 2026 Bonfanti P.Parati G.Perger E. +
Proportion of newly diagnosed persons with HIV with HIV-RNA greater than/equal to 500 000 copies/mL in 2018–2023 in Italy: data from the ICONA Foundation Cohort Study 01 - Articolo su rivista 2026 Lapadula G.Puoti M.Bonfanti P. +
Real-world use of cefiderocol as monotherapy or combination therapy for the treatment of Gram-negative bacterial infections: the multicentre retrospective CEFI-BAC study 01 - Articolo su rivista 2026 Bonfanti, Paolo +
Reduced Emergency Department Visits and Hospitalizations in Infants after Universal Respiratory Syncytial Virus Immunization, Italy, 2024-25 01 - Articolo su rivista 2026 Bonfanti Paolo +
Safety and efficacy of switching to bictegravir-lenacapavir versus continuing bictegravir-emtricitabine-tenofovir alafenamide in virologically suppressed people with HIV-1 (ARTISTRY-2): a double-blind, multicentre, randomised, controlled, phase 3, non-inferiority trial 01 - Articolo su rivista 2026 Bonfanti Paolo +
Urinary antigen-negative Legionella pneumonia in critically ill patients: value of systematic molecular testing for optimal antimicrobial therapy 01 - Articolo su rivista 2026 Foglia Manzillo, LiviaTeggia Droghi, MaddalenaFoti, GiuseppeBonfanti, PaoloGiani, Marco +
Administration of antivirals, IL-6 inhibitors, monoclonal neutralizing antibodies and systemic corticosteroids in acute SARS-CoV-2 infection do not reduce the subsequent burden of Long-COVID symptoms 01 - Articolo su rivista 2025 Bonfanti, PaoloParati, Gianfranco +
Adolescents with Persistent Symptoms Following Acute SARS-CoV-2 Infection (Long-COVID): Symptom Profile, Clustering and Follow-Up Symptom Evaluation 01 - Articolo su rivista 2025 Elisa, PergerParati, GianfrancoBonfanti, Paolo +
Adverse event development in people with HIV on long-acting Cabotegravir + rilpivirine: timing and clinical insights 02 - Intervento a convegno 2025 Bonfanti, P +